Skip to main content

Table 3 Association of Baseline Blood Biomarkers and δ Changes at 4 Weeks (4 Weeks – Baseline) and Recurrence after 3 Months of Immunotherapy

From: Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Biomarker

OR (95% CI) N = 48

P Value

WBC

1.18 (1.04, 1.34)

0.011

ANC

1.20 (1.04, 1.38)

0.014

ALC

1.62 (0.75, 3.48)

0.22

AMC

3.11 (0.96, 10,05)

0.059

AEC (Eosinophil)

1.77 (0.42, 7.38)

0.44

Platelets

1.11 (0.90, 1.37)

0.32

ANC/ALC

1.02 (0.96, 1.09)

0.54

M:L ratio

1.02 (0.96, 1.09)

0.52

  1. P-values given is based on logistic regression model
Back to article page